American Society of Hematology

SHERPA: Blue

People

  1. Giralt
    Giralt
  2. Zelenetz
    Zelenetz
  3. Levine
    Levine
  4. Tallman
    Tallman
  5. Perales
    Perales
  6. O'Reilly
    O'Reilly
  7. Horwitz
    Horwitz
  8. Devlin
    Devlin
  9. Kernan
    Kernan
  10. Abdel-Wahab
    Abdel-Wahab

Groups

  1. Department of Medicine (3844)
  2. Hematologic Malignancies, Division of (3639)
  3. Center for Hematologic Malignancies (3542)
  4. GSK Faculty (1553)
  5. Adult Leukemia (1289)
  6. Sloan Kettering Institute Faculty (1065)
  7. Bone Marrow Transplant (936)
  8. Center for Molecular Imaging and Biotechnology (CMIB) (931)
  9. Lymphoma (898)
  10. Tow Center for Developmental Oncology (TCDO) (863)
Search Within
Formats
  1. Meeting Abstract (3939)
  2. Journal Article (1239)
  3. Research Letter (44)
  4. Review (44)
  5. Editorial (34)
  6. Guidelines (13)
  7. Correspondence (7)
  8. Miscellaneous (3)
Groups
  1. Department of Medicine (3844)
  2. Hematologic Malignancies, Division of (3639)
  3. Center for Hematologic Malignancies (3542)
  4. GSK Faculty (1553)
  5. Adult Leukemia (1289)
  6. Sloan Kettering Institute Faculty (1065)

More Groups

People
  1. Sergio Giralt (337)
  2. Andrew Zelenetz (328)
  3. Ross Levine (312)
  4. Martin Tallman (298)
  5. Miguel-Angel Perales (292)
  6. Richard O'Reilly (281)

More People

Years
  1. 2025 (43)
  2. 2024 (217)
  3. 2023 (478)
  4. 2022 (369)
  5. 2021 (284)
  6. 2020 (261)

More Years

Publications
  1. Blood (4951)
  2. Blood Advances (322)
  3. Hematology-American Society of Hematology Education Program (50)

Results (5323)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Crebbp inhibition potentiates JAK2 inhibition in post-MPN acute myeloid leukemia
    Meeting Abstract

    Bertulfo, K.; Miller, H.; Najac, R.; Castelan, J. C.; Ma, C.; Debackere, K.; Xiao, W.; Rampal, R.; Levine, R. L.; Lu, C.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • The histone acetyltransferase MOZ (KAT6A) is a molecular dependency and therapeutic target in NUP98-rearranged acute myeloid leukemia
    Meeting Abstract

    Michmerhuizen, N. L.; Heikamp, E.; Umeda, M.; Iacobucci, I.; Arthur, B.; Di Giacomo, D.; Hiltenbrand, R.; Radko-Juettner, S.; Portola, P.; Claquin, A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Evolution of survival disparities among adolescents and young adults with AML in the US
    Meeting Abstract

    Feliciano, E. G.; Dee, E. C.; Wu, J. F.; Martinez, J.; Singh, A.; Shah, N.; Jain, U.
    Blood (2024)

    Fulltext@MSK | Save
  • Outcomes offrailty subgroups treated with teclistamab in the real-world: An International Myeloma Foundation study database analysis
    Meeting Abstract

    Mian, H.; Tan, C. R.; Asoori, S.; Popat, R.; Abdallah, N.; Chhabra, S.; Parrondo, R. D.; Pond, G. R.; Martin, T.; Durie, B. G. M.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Patient-centered care in hematology: How side effect severity influences decision-making autonomy in relapsed refractory multiple myeloma
    Meeting Abstract

    Martinez, J. A. H.; Quiroz, F. F.; Ahlstrom, J. M.; Fonseca, R.; Strain, J. R.; Iadeluca, L.; Jensen, R. M.; Chmielewski, C.; Usmani, S. Z.; Hydren, J. R.
    Blood (2024)

    Fulltext@MSK | Save
  • A single cell atlas of follicular lymphoma across clinical stages defines tumor B cell archetypes, immune microenvironment heterogeneity and novel cell states associated with high-risk FL
    Meeting Abstract

    Sarrabay, A.; Baaklini, S.; Barthelemy, C.; Gil, L.; Beyou, A.; Dahbi, L.; Mossadegh-Keller, N.; Huber, C.; Navarro, J. M.; Salles, G.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • ELA026, a monoclonal antibody targeting signal regulatory protein-α/β1/γ, rapidly controls inflammation and improves 2-month survival in treatment-naïve malignancy-associated hemophagocytic lymphohistiocytosis
    Meeting Abstract

    Maiti, A.; Daver, N.; Johnson, W. T.; Goyal, G.; Broome, C. M.; Gohil, S.; Van Laar, J.; Jimenez, J. L.; McCall, D.; Lane, H.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Efficacy and safety of brexucabtagene autoleucel for relapsed/refractory B-cell acute lymphoblastic leukemia in patients aged 60 and above
    Meeting Abstract

    Muhsen, I.; Advani, A. S.; Roloff, G. W.; Jeyakumar, N.; Miller, K.; Zhang, A.; Sutherland, K. C.; Grunwald, M. R.; Kota, V. K.; Boccucci, J.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Outcomes of patients with IDH1/2 mutated accelerated/blast-phase myeloproliferative neoplasms in the era of IDH inhibitors
    Meeting Abstract

    Goldberg, L. A.; Yoon, J. J.; Johnston, H.; Davidson, M. B.; Siddon, A.; Shallis, R. M.; Chen, E. C.; Burkart, M.; Oh, T. S.; Iyer, S. G.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Dual-vector-transduction with single-step magnetic selection (Zip-sort) increases transgenic payloads to enhance CAR T cell activity
    Meeting Abstract

    James, S. E.; Chen, S.; Ng, B.; Fischman, J.; Jahn, L.; Boardman, A. P.; Rajagopalan, A.; Elias, H. K.; Massa, A. R.; Manuele, D.; more...
    Blood (2024)

    Fulltext@MSK | Save